ライフサイエンスコーパス: povidone

1 n spectra, revealing direct contacts between povidone and the API.

2 to include use of a sterile lid speculum and povidone iodine (5%).

3 reparation wipes (alcohol, chlorhexidine and povidone iodine) and found that during wiping they reduc

4 was swept with a culture swab before use of povidone iodine; the inferior fornix of the fellow eye w

5 sinfection with polyvinylpyrrolidone (PVP or povidone)-iodine-alcohol and the correlation with postop

6 assigned to receive oropharyngeal care with povidone-iodine (n = 91) or placebo (n = 88) six times d

7 plants were exposed to three antimicrobials: povidone-iodine (PovI; 0.05%, 1%, and 5%), chlorhexidine

8 Povidone-iodine (PVI) is principally used as an antimicr

9 This review article addresses the effects of povidone-iodine (PVP-I) and its utility in the treatment

10 ) for presumed cure among those treated with povidone-iodine (vs antibiotics) was 1.46 in the Philipp

11 ant difference between the effect of topical povidone-iodine 1.25% and topical antibiotics commonly a

12 To compare povidone-iodine 1.25% ophthalmic solution with topical a

13 Povidone-iodine 1.25%, which is widely available and ine

14 preparation for intravitreal injection using povidone-iodine 5% alone in the absence of postinjection

15 The preoperative use of povidone-iodine 5% and the postoperative use of impregna

16 paration consisted of topical anesthetic and povidone-iodine 5% without the use of preinjection or po

17 The preoperative use of povidone-iodine 5%, dilute intracameral antibiotics (via

18 cohol was significantly more protective than povidone-iodine against both superficial incisional infe

19 .5 to 0.7 days) and in India was 12 days for povidone-iodine and 17 days for ciprofloxacin (95% CI, -

20 sumed cure in the Philippines was 7 days for povidone-iodine and 7 days for neomycin-polymyxin B-gram

21 opriate wound construction, a combination of povidone-iodine and antibiotics provide a reasonable app

22 Continued use of povidone-iodine and consideration to eliminate topical a

23 ement: The subxyphoid area was cleansed with povidone-iodine and draped.

24 ng intravitreous injections with and without povidone-iodine and rates with and without topical antib

25 doxycycline, 100 mg for 2 weeks; 3) topical povidone-iodine and systemic doxycycline, 100 mg for 2 w

26 Objective: To assess whether povidone-iodine application at the end of adjustable sut

27 echanical debridement measures with adjuvant Povidone-iodine application with and without systemic an

28 echanical debridement measures with adjuvant povidone-iodine application with and without systemic an

29 s for repair of cardiac defects and received povidone-iodine as a preoperative antiseptic.

30 This study was not able to demonstrate that povidone-iodine at the end of adjustable suture strabism

31 was to test the hypothesis that preoperative povidone-iodine contributes to postoperative thyroid dep

32 ine washcloths and oral rinse and intranasal povidone-iodine decreased the SSI rate by more than 50%

33 Interventions: One drop of 5% povidone-iodine directly over the sliding noose of the a

34 xidine-alcohol is superior to cleansing with povidone-iodine for preventing surgical-site infection a

35 de, 0.12% chlorhexidine digluconate, or 7.5% povidone-iodine for subgingival irrigation during SRP.

36 the chlorhexidine-alcohol group than in the povidone-iodine group (9.5% vs. 16.1%; P=0.004; relative

37 eumonia occurred in 24 patients (31%) in the povidone-iodine group and 20 (28%) in the placebo group

38 acheobronchitis: eight patients (10%) in the povidone-iodine group and five patients (7%) in the plac

39 ss syndrome occurred in five patients in the povidone-iodine group but not in the placebo group (p =

40 The povidone-iodine group had the highest clinical improveme

41 e chlorhexidine-alcohol group and 440 in the povidone-iodine group) qualified for the intention-to-tr

42 tion-to-treat population) was 150 (78 in the povidone-iodine group, 72 in the placebo group).

43 ares favorably with previous series in which povidone-iodine has been used.

44 e regarding the risk of endophthalmitis when povidone-iodine is not used before intravitreous injecti

45 only a small number of eyes did not receive povidone-iodine just prior to an intravitreous injection

46 onic debridement, STC and GPAP with adjuvant Povidone-iodine led to significant clinical improvements

47 nic debridement, STC, and GPAP with adjuvant povidone-iodine led to significant clinical improvements

48 tion shields for pulmonary artery catheters; povidone-iodine ointment applied to insertion sites of h

49 acterial keratitis to topical treatment with povidone-iodine or antibiotics (neomycin-polymyxin B-gra

50 Preoperative application of povidone-iodine remains the standard protocol for the pr

51 n with either chlorhexidine-alcohol scrub or povidone-iodine scrub and paint.

52 orhexidine skin cleanser was substituted for povidone-iodine solution during initial aseptic preparat

53 hexidine washcloths and oral rinse and nasal povidone-iodine solution to be used the night before and

54 e effective for catheter insertion care than povidone-iodine solutions to prevent catheter-associated

55 e is no evidence to recommend oral care with povidone-iodine to prevent ventilator-associated pneumon

56 rgery is not well defined, and the effect of povidone-iodine use on suture colonization is unknown.

57 No adverse effects of povidone-iodine were observed.

58 0% isopropyl alcohol, tincture of iodine, or povidone-iodine with 70% ethyl alcohol (i.e., Persist).

59 1 (with povidone-iodine) or group 2 (without povidone-iodine) at the end of surgery.

60 ing assigned participants into group 1 (with povidone-iodine) or group 2 (without povidone-iodine) at

61 ation rates were determined to be 2.93% with povidone-iodine, 2.58% with tincture of iodine, 2.50% wi

62 Skin antisepsis was performed with 10% povidone-iodine, 70% isopropyl alcohol, tincture of iodi

63 28773 injections (3120 eyes) performed with povidone-iodine, 9 cases of endophthalmitis occurred: 6

64 er 12 months (P = 0.045 and P = 0.002) using povidone-iodine.

65 ght benefit seemed to derive from the use of povidone-iodine.

66 is more protective against infection than is povidone-iodine.

67 of iodine rather than isopropyl alcohol plus povidone-iodine.

68 AP) and a repeated submucosal application of Povidone-iodine.

69 P), and a repeated submucosal application of povidone-iodine.

70 rom 2 participants were administered without povidone-iodine; both participants developed endophthalm

71 re divided into two groups: Group 1 received povidone-iodine; group 2 received chlorhexidine as a top